Aaron C. Logan MD, PhD
Associate Professor, Hematology, BMT, & Cellular Therapy, University of California, San Francisco, CaliforniaDr. Aaron Logan is an Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF) in the Division of Hematology, Blood and Marrow Transplantation, and Cellular Therapy. His clinical practice focuses on the management of patients with acute leukemias, myelodysplastic syndrome, aplastic anemia and hemophagocytic lymphohistiocytosis. Dr. Logan is a specialist in non-transplant, transplant, and cellular therapies. Dr. Logan also runs a research laboratory and is Director of the Hematologic Malignancies Tissue Bank at UCSF. His research interests focus on the application of next generation sequencing of immunoreceptor genes to quantify measurable residual disease (aka, minimal residual disease) in acute lymphoblastic leukemia, quantify B and T cell immune reconstitution after allogeneic hematopoietic cell transplantation, and to quantify and track malignancy-, pathogen-, and autoantigen-targeted immune responses following transplantation or immunotherapy.
Disclosures
Research Funding: Amgen, Astellas, Autolus, Jazz, Kadmon, Kite, Pharmacyclics
Consulting: Abbvie, Bristol-Myers Squibb, Pfizer